No major effects of vitamin D3 (1,25 dihydroxyvitamin D3) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers.
Kullak-Ublick, Gerd A
No major effects of vitamin D3 (1,25 dihydroxyvitamin D3) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers. [electronic resource] - European journal of clinical pharmacology Jul 2016 - 797-805 p. digital
Publication Type: Clinical Trial; Journal Article
1432-1041
10.1007/s00228-016-2050-0 doi
ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics
Administration, Oral
Adult
Duodenum--drug effects
Female
Folic Acid--blood
Healthy Volunteers
Humans
Intestinal Absorption--drug effects
Male
Multidrug Resistance-Associated Proteins--genetics
Organic Anion Transporters--genetics
Proton-Coupled Folate Transporter--genetics
RNA, Messenger--metabolism
Terfenadine--analogs & derivatives
Vitamin D--analogs & derivatives
Young Adult
No major effects of vitamin D3 (1,25 dihydroxyvitamin D3) on absorption and pharmacokinetics of folic acid and fexofenadine in healthy volunteers. [electronic resource] - European journal of clinical pharmacology Jul 2016 - 797-805 p. digital
Publication Type: Clinical Trial; Journal Article
1432-1041
10.1007/s00228-016-2050-0 doi
ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics
Administration, Oral
Adult
Duodenum--drug effects
Female
Folic Acid--blood
Healthy Volunteers
Humans
Intestinal Absorption--drug effects
Male
Multidrug Resistance-Associated Proteins--genetics
Organic Anion Transporters--genetics
Proton-Coupled Folate Transporter--genetics
RNA, Messenger--metabolism
Terfenadine--analogs & derivatives
Vitamin D--analogs & derivatives
Young Adult